The Binding Site

The Binding Site is a UK-based international diagnostics company that specializes in the research, development, manufacture, and distribution of innovative tests for blood cancers and immune system disorders. Founded in 1983 by researchers from the University of Birmingham, the company has established a strong reputation for producing highly sensitive and specific diagnostic tests. The Binding Site offers a broad portfolio of diagnostic tests, with a focus on protein diagnostics related to blood cancers, particularly multiple myeloma. Its flagship product, the Freelite® serum-free light-chain assay, is widely used for diagnosing and monitoring multiple myeloma. The company also developed the Optilite instrument, which supports its business model by combining instrument sales with ongoing consumable test sales. With a global presence in over 95 countries, The Binding Site serves clinical laboratories, hospitals, and healthcare providers, ensuring access to its recognized diagnostic solutions.

• Employees590
• Founded1983